153 related articles for article (PubMed ID: 37974385)
61. A method for evaluation of proton plan robustness towards inter-fractional motion applied to pelvic lymph node irradiation.
Andersen AG; Casares-Magaz O; Muren LP; Toftegaard J; Bentzen L; Thörnqvist S; Petersen JB
Acta Oncol; 2015; 54(9):1643-50. PubMed ID: 26203931
[TBL] [Abstract][Full Text] [Related]
62. Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy.
Ding X; Li X; Zhang JM; Kabolizadeh P; Stevens C; Yan D
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1107-1116. PubMed ID: 27869083
[TBL] [Abstract][Full Text] [Related]
63. Strategies for Motion Robust Proton Therapy With Pencil Beam Scanning for Esophageal Cancer.
Møller DS; Poulsen PR; Hagner A; Dufour M; Nordsmark M; Nyeng TB; Mortensen HR; Lutz CM; Hoffmann L
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):539-548. PubMed ID: 33974885
[TBL] [Abstract][Full Text] [Related]
64. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
[TBL] [Abstract][Full Text] [Related]
65. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
66. Impact of errors in spot size and spot position in robustly optimized pencil beam scanning proton-based stereotactic body radiation therapy (SBRT) lung plans.
Rana S; Rosenfeld AB
J Appl Clin Med Phys; 2021 Jul; 22(7):147-154. PubMed ID: 34101334
[TBL] [Abstract][Full Text] [Related]
67. On the beam direction search space in computerized non-coplanar beam angle optimization for IMRT-prostate SBRT.
Rossi L; Breedveld S; Heijmen BJ; Voet PW; Lanconelli N; Aluwini S
Phys Med Biol; 2012 Sep; 57(17):5441-58. PubMed ID: 22864234
[TBL] [Abstract][Full Text] [Related]
68. Proton pencil beam scanning craniospinal irradiation (CSI) with a single posterior brain beam: Dosimetry and efficiency.
Hu L; Zhai A; Chen Q; Puri V; Chen CC; Yu F; Fox J; Wolden S; Yang J; Simone CB; Lin H
Med Dosim; 2024 Spring; 49(1):25-29. PubMed ID: 38040549
[TBL] [Abstract][Full Text] [Related]
69. PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection.
Rojo-Santiago J; Korevaar E; Perkó Z; Both S; Habraken SJM; Hoogeman MS
Radiother Oncol; 2023 Sep; 186():109729. PubMed ID: 37301261
[TBL] [Abstract][Full Text] [Related]
70. Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer.
Stefanowicz S; Stützer K; Zschaeck S; Jakobi A; Troost EGC
Radiat Oncol; 2018 Nov; 13(1):228. PubMed ID: 30466468
[TBL] [Abstract][Full Text] [Related]
71. Fraction optimization for hybrid proton-photon treatment planning.
Li W; Zhang W; Lin Y; Chen RC; Gao H
Med Phys; 2023 Jun; 50(6):3311-3323. PubMed ID: 36786202
[TBL] [Abstract][Full Text] [Related]
72. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy.
Leung WS; Wu VWC; Liu CYW; Cheng ACK
J Appl Clin Med Phys; 2019 Nov; 20(11):121-130. PubMed ID: 31593367
[TBL] [Abstract][Full Text] [Related]
73. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
[TBL] [Abstract][Full Text] [Related]
74. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
Yuan L; Ge Y; Lee WR; Yin FF; Kirkpatrick JP; Wu QJ
Med Phys; 2012 Nov; 39(11):6868-78. PubMed ID: 23127079
[TBL] [Abstract][Full Text] [Related]
75. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
[TBL] [Abstract][Full Text] [Related]
76. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
An Y; Liang J; Schild SE; Bues M; Liu W
Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
[TBL] [Abstract][Full Text] [Related]
77. Plan-library supported automated replanning for online-adaptive intensity-modulated proton therapy of cervical cancer.
Jagt TZ; Breedveld S; van Haveren R; Nout RA; Astreinidou E; Heijmen BJM; Hoogeman MS
Acta Oncol; 2019 Oct; 58(10):1440-1445. PubMed ID: 31271076
[No Abstract] [Full Text] [Related]
78. Dosimetric impact of random spot positioning errors in intensity modulated proton therapy plans of small and large volume tumors.
Arjunan M; Krishnan G; Sharma DS; M P N; Patro KC; Thiyagarajan R; Srinivas C; Jalali R
Br J Radiol; 2021 Mar; 94(1119):20201031. PubMed ID: 33529057
[TBL] [Abstract][Full Text] [Related]
79. Effect of intrafraction prostate motion on proton pencil beam scanning delivery: a quantitative assessment.
Tang S; Deville C; McDonough J; Tochner Z; Wang KK; Vapiwala N; Both S
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):375-82. PubMed ID: 23958148
[TBL] [Abstract][Full Text] [Related]
80. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
